Caspofungin acetate is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other anti-fungal therapy.
- Candidemia and the following Candida infections: intra-abdominal abscesses, peritonitis and pleural space infections.
- Note: not well studied in endocarditis, osteomyelitis, and meningitis (low CNS penetration) due to Candida.
- Esophageal candidiasis (authors’ opinion: would reserve caspofungin for azole-resistant cases).
- Empiric treatment of presumed fungal infections in febrile neutropenic patients.
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: May 1, 2017
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Caspofungin acetate
ID - 540083
A1 - Bartlett,John,M.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2017/05/01/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540083/all/Caspofungin_acetate
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -